Literature DB >> 2011143

Is environmental carcinogenesis modulated by host polymorphism?

J R Idle1.   

Abstract

It is now clear that tobacco smoking, alcohol consumption, dietary factors and occupation can all interact with genetic host factors to place one individual at a greater or lesser risk of a particular cancer than another. Phenotypes which confer significantly elevated risks arise from the human CYP1A1. CYP2D6, GST1 and NAT (N-acetyltransferase) genes. The last is the only one remaining to be cloned. It is envisaged that several of these genes may interact in a given circumstance cooperatively to increase susceptibility. For example CYP1A1, CYP2D6 and GST1 genotypes may have additive or multiplicative risks of bronchogenic carcinoma in cigarette smokers. CYP2D6 and NAT genotypes may interact in bladder cancer. The advent of molecular genetics brings us closer to the day when, for example, factory workers in potentially hazardous environments might be screened using PCR methodology on skin scrapings or buccal swabs for their innate susceptibility to combined workplace and lifestyle cancer risks.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011143     DOI: 10.1016/0027-5107(91)90021-f

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  16 in total

1.  GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer.

Authors:  Beray Kiran; Mutlu Karkucak; Hakan Ozan; Tahsin Yakut; Kemal Ozerkan; Sebnem Sag; Mehmet Ture
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 2.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

3.  Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.

Authors:  WeiYing Li; WenTao Yue; LiNa Zhang; XiaoTing Zhao; Li Ma; XueHui Yang; ChunYan Zhang; Yue Wang; Meng Gu
Journal:  Lung       Date:  2011-11-23       Impact factor: 2.584

Review 4.  Combinations of susceptible genotypes and individual responses to toxicants.

Authors:  A Hirvonen
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

5.  Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer's patients with tacrine transaminitis.

Authors:  V J Green; M Pirmohamed; N R Kitteringham; M J Knapp; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

Review 6.  Studying environmental influences and breast cancer risk: suggestions for an integrated population-based approach.

Authors:  R Millikan; E DeVoto; B Newman; D Savitz
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

7.  Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients.

Authors:  Prachi Bajpai; Anil Kumar Tripathi; Deepa Agrawal
Journal:  Mol Cell Biochem       Date:  2009-10-13       Impact factor: 3.396

8.  Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.

Authors:  A D Spigelman; K C Farmer; S Oliver; K P Nugent; P N Bennett; L J Notarianni; P Dobrocky; R K Phillips
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

Review 9.  Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.

Authors:  O Pelkonen; H Raunio
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

10.  The HPRT short-term assay in monitoring individuals exposed to genotoxic agents.

Authors:  R Montero; M E Gonsebatt; L A Herrera; E Rojas; P Ostrosky-Wegman
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.